Enhanced Heterogeneous Fenton-like Process for Sulfamethazine Removal via Dual-Reaction-Center Fe-Mo/rGO Catalyst.

Weihua Qin, Yueming Ma, Ting He, Jingbin Hu, Pan Gao, Shaoxia Yang

Open access · goldAbstract read

In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.7field-weighted citation impact, top 34% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 9 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Weihua QinSchool of Water Resources and Hydropower Engineering, North China Electric Power University, Beijing 102206, China.

Yueming MaNational Engineering Laboratory for Biomass Power Generation Equipment, School of Renewable Energy, North China Electric Power University, Beijing 102206, China.

Ting HeSchool of Water Resources and Hydropower Engineering, North China Electric Power University, Beijing 102206, China.

Jingbin HuSchool of Water Resources and Hydropower Engineering, North China Electric Power University, Beijing 102206, China.

Pan GaoNational Engineering Laboratory for Biomass Power Generation Equipment, School of Renewable Energy, North China Electric Power University, Beijing 102206, China.ORCID 0000-0001-8735-5151

Shaoxia YangSchool of Water Resources and Hydropower Engineering, North China Electric Power University, Beijing 102206, China.

North China Electric Power University · CN

Funding

National Major Science and Technology Program for Water Pollution Control and Treatment 2017ZX07101003

6 · The paper itself

Abstract

A heterogeneous Fenton-like catalyst with single redox site has a rate-limiting step in oxidant activation, which limited its application in wastewater purification. To overcome this, a bimetallic doping strategy was designed to prepare a heterogeneous Fenton-like catalyst (Fe-Mo/rGO) with a double-reaction center. Combined with electrochemical impedance spectroscopy and density functional theory calculation, it was confirmed that the formation of an electron-rich Mo center and an electron-deficient Fe center through the constructed Fe-O-Mo and Mo-S-C bonding bridges induced a higher electron transfer capability in the Fe-Mo/rGO catalyst. The designed Fe-Mo/rGO catalyst exhibited excellent sulfamethazine (SMT) degradation efficiency in a broad pH range (4.8-8.4). The catalytic performance was hardly affected by inorganic anions (Cl

Indexed as

Fe-Mo dual-reaction-center catalystheterogeneous Fenton-like reactionreactive oxygen speciessulfamethazine

Identifiers

PMID36500765

DOI10.3390/nano12234138

PMCPMC9740472

OpenAlexW4309847897

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.